Treating infectious diseases in a microbial world: report of two workshops on novel antimicrobial therapeutics
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
©2006
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 Includes bibliographical references Challenges for the Development of New Antimicrobials: Rethinking the Approaches: Report of a Workshop -- Promising Approaches to the Development of Immunomodulation for the Treatment of Infectious Diseases: Report of a Workshop Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic |
| Beschreibung: | 1 Online-Ressource (x, 92 pages) |
| ISBN: | 0309100569 0309654904 9780309100564 9780309654906 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043097489 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2006 |||| o||u| ||||||eng d | ||
| 020 | |a 0309100569 |9 0-309-10056-9 | ||
| 020 | |a 0309654904 |9 0-309-65490-4 | ||
| 020 | |a 9780309100564 |9 978-0-309-10056-4 | ||
| 020 | |a 9780309654906 |9 978-0-309-65490-6 | ||
| 035 | |a (OCoLC)63665050 | ||
| 035 | |a (DE-599)BVBBV043097489 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 615.329 |2 22 | |
| 110 | 2 | |a National Research Council (U.S.) |b Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Treating infectious diseases in a microbial world |b report of two workshops on novel antimicrobial therapeutics |c Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials ; Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c ©2006 | |
| 300 | |a 1 Online-Ressource (x, 92 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a Challenges for the Development of New Antimicrobials: Rethinking the Approaches: Report of a Workshop -- Promising Approaches to the Development of Immunomodulation for the Treatment of Infectious Diseases: Report of a Workshop | ||
| 500 | |a Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic | ||
| 650 | 4 | |a Anti-Infective Agents / therapeutic use | |
| 650 | 4 | |a Anti-Bacterial Agents / therapeutic use | |
| 650 | 4 | |a Communicable Diseases / drug therapy | |
| 650 | 4 | |a Immunologic Factors / therapeutic use | |
| 650 | 4 | |a Immune System / physiopathology | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Anti-infective agents / Therapeutic use |2 fast | |
| 650 | 7 | |a Communicable diseases / Treatment |2 fast | |
| 650 | 7 | |a Infection / Treatment |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Anti-infective agents |x Therapeutic use |v Congresses | |
| 650 | 4 | |a Communicable diseases |x Treatment |v Congresses | |
| 650 | 4 | |a Infection |x Treatment |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 710 | 2 | |a National Research Council (U.S.) |b Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=148934 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028521681 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=148934 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=148934 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175504145645568 |
|---|---|
| any_adam_object | |
| author_corporate | National Research Council (U.S.) Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials |
| author_corporate_role | aut |
| author_facet | National Research Council (U.S.) Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials |
| author_sort | National Research Council (U.S.) Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials |
| building | Verbundindex |
| bvnumber | BV043097489 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)63665050 (DE-599)BVBBV043097489 |
| dewey-full | 615.329 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.329 |
| dewey-search | 615.329 |
| dewey-sort | 3615.329 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03836nmm a2200577zc 4500</leader><controlfield tag="001">BV043097489</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2006 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309100569</subfield><subfield code="9">0-309-10056-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309654904</subfield><subfield code="9">0-309-65490-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309100564</subfield><subfield code="9">978-0-309-10056-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309654906</subfield><subfield code="9">978-0-309-65490-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)63665050</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043097489</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.329</subfield><subfield code="2">22</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">National Research Council (U.S.)</subfield><subfield code="b">Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treating infectious diseases in a microbial world</subfield><subfield code="b">report of two workshops on novel antimicrobial therapeutics</subfield><subfield code="c">Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials ; Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">©2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 92 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Challenges for the Development of New Antimicrobials: Rethinking the Approaches: Report of a Workshop -- Promising Approaches to the Development of Immunomodulation for the Treatment of Infectious Diseases: Report of a Workshop</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Infective Agents / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Bacterial Agents / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable Diseases / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunologic Factors / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune System / physiopathology</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-infective agents / Therapeutic use</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Communicable diseases / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Infection / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-infective agents</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable diseases</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infection</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Research Council (U.S.)</subfield><subfield code="b">Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=148934</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028521681</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=148934</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=148934</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV043097489 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:20Z |
| institution | BVB |
| isbn | 0309100569 0309654904 9780309100564 9780309654906 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028521681 |
| oclc_num | 63665050 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (x, 92 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | National Research Council (U.S.) Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials Verfasser aut Treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials ; Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies Washington, D.C. National Academies Press ©2006 1 Online-Ressource (x, 92 pages) txt rdacontent c rdamedia cr rdacarrier Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 Includes bibliographical references Challenges for the Development of New Antimicrobials: Rethinking the Approaches: Report of a Workshop -- Promising Approaches to the Development of Immunomodulation for the Treatment of Infectious Diseases: Report of a Workshop Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic Anti-Infective Agents / therapeutic use Anti-Bacterial Agents / therapeutic use Communicable Diseases / drug therapy Immunologic Factors / therapeutic use Immune System / physiopathology MEDICAL / Pharmacology bisacsh Anti-infective agents / Therapeutic use fast Communicable diseases / Treatment fast Infection / Treatment fast Medizin Anti-infective agents Therapeutic use Congresses Communicable diseases Treatment Congresses Infection Treatment Congresses (DE-588)1071861417 Konferenzschrift gnd-content National Research Council (U.S.) Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=148934 Aggregator Volltext |
| spellingShingle | Treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics Anti-Infective Agents / therapeutic use Anti-Bacterial Agents / therapeutic use Communicable Diseases / drug therapy Immunologic Factors / therapeutic use Immune System / physiopathology MEDICAL / Pharmacology bisacsh Anti-infective agents / Therapeutic use fast Communicable diseases / Treatment fast Infection / Treatment fast Medizin Anti-infective agents Therapeutic use Congresses Communicable diseases Treatment Congresses Infection Treatment Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics |
| title_auth | Treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics |
| title_exact_search | Treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics |
| title_full | Treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials ; Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies |
| title_fullStr | Treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials ; Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies |
| title_full_unstemmed | Treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials ; Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies |
| title_short | Treating infectious diseases in a microbial world |
| title_sort | treating infectious diseases in a microbial world report of two workshops on novel antimicrobial therapeutics |
| title_sub | report of two workshops on novel antimicrobial therapeutics |
| topic | Anti-Infective Agents / therapeutic use Anti-Bacterial Agents / therapeutic use Communicable Diseases / drug therapy Immunologic Factors / therapeutic use Immune System / physiopathology MEDICAL / Pharmacology bisacsh Anti-infective agents / Therapeutic use fast Communicable diseases / Treatment fast Infection / Treatment fast Medizin Anti-infective agents Therapeutic use Congresses Communicable diseases Treatment Congresses Infection Treatment Congresses |
| topic_facet | Anti-Infective Agents / therapeutic use Anti-Bacterial Agents / therapeutic use Communicable Diseases / drug therapy Immunologic Factors / therapeutic use Immune System / physiopathology MEDICAL / Pharmacology Anti-infective agents / Therapeutic use Communicable diseases / Treatment Infection / Treatment Medizin Anti-infective agents Therapeutic use Congresses Communicable diseases Treatment Congresses Infection Treatment Congresses Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=148934 |
| work_keys_str_mv | AT nationalresearchcounciluscommitteeonnewdirectionsinthestudyofantimicrobialtherapeuticsnewclassesofantimicrobials treatinginfectiousdiseasesinamicrobialworldreportoftwoworkshopsonnovelantimicrobialtherapeutics AT nationalresearchcounciluscommitteeonnewdirectionsinthestudyofantimicrobialtherapeuticsimmunomodulation treatinginfectiousdiseasesinamicrobialworldreportoftwoworkshopsonnovelantimicrobialtherapeutics |